1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
申请人:——
公开号:US20030109539A1
公开(公告)日:2003-06-12
The present invention is directed to novel 1,3,8-triazaspiro[4.5]decan-4-one derivatives of the general formula
1
wherein all variables are as defined herein, useful in the treatment of disorders and conditions mediated by the ORL-1 G-protein coupled receptor. More particularly, the compounds of the present invention are useful in the treatment of disorders and conditions such as anxiety, depression, substance abuse, neuropathic pain, acute pain, migraine, asthma, cough and for improved cognition.
本发明涉及一种新颖的一舁3,8-三氮杂螺[4.5]癸烷-4-酮衍生物,其一般式如下:
1
其中所有变量如本文所定义,在治疗由ORL-1 G蛋白偶联受体介导的疾病和症状中有用。更具体地,本发明的化合物在治疗焦虑、抑郁、物质滥用、神经病痛、急性疼痛、偏头痛、哮喘、咳嗽和改善认知方面有用。